The EASL guidelines on the clinical management of hereditary cholestatic liver disease, published in 2024, suggest that genetic testing should be performed as early as possible in the diagnostic process after ruling out common causes. Along with a better understanding of the genes and proteins involved in biliary homeostasis and the increasing availability of genetic testing, more and more patients with adult-onset cholestasis are being tested for cholestasis genes that play a role in progressive intrahepatic familial cholestasis (PFIC).
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Prurigo nodularis: evidence-based treatment
Targeted therapy options on the rise
- MACE risk, heart failure incidence and all-cause mortality
Metabolic syndrome as a cardiovascular risk factor
- Glaucoma in old age: slowing down progression
IOP lowering is currently the only evidence-based treatment
- Vector-borne infections with skin manifestations
Arboviruses and leishmaniasis in Europe
- Multimorbidity and functional capacity in old age
Clarify individual health status and reduce risks
- Tick season: danger from early summer meningoencephalitis
TBE vaccination recommended for adults and children aged 3 and over
- New WHO guideline, updated stimulation protocols, focus on PGT-A
Fertility and reproductive medicine 2026
- Proteins in wound healing